405 related articles for article (PubMed ID: 29274704)
1. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors.
Huang D; Li W; Zhao Y; Xie C; Luo X; Wu F; Xu Z; Sun Q; Liu G
Eur J Med Chem; 2024 May; 271():116443. PubMed ID: 38691887
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.
Chen S; Zhang T; Wang J; Wang F; Niu H; Wu C; Wang S
Eur J Med Chem; 2015 Oct; 103():343-53. PubMed ID: 26363870
[TBL] [Abstract][Full Text] [Related]
9. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
[TBL] [Abstract][Full Text] [Related]
11. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the inhibition effect of thymoquinone on xanthine oxidase activity using differential pulse voltammetry in combination with theoretical studies.
Rezaeinasab M; Benvidi A; Gharaghani S; Abbasi S; Zare HR
Enzyme Microb Technol; 2019 Feb; 121():29-36. PubMed ID: 30554642
[TBL] [Abstract][Full Text] [Related]
13. Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors.
Nishiwaki K; Ohigashi K; Deguchi T; Murata K; Nakamura S; Matsuda H; Nakanishi I
Chem Pharm Bull (Tokyo); 2018 Jul; 66(7):741-747. PubMed ID: 29695658
[TBL] [Abstract][Full Text] [Related]
14. 2-styrylchromones as novel inhibitors of xanthine oxidase. A structure-activity study.
Fernandes E; Carvalho F; Silva AM; Santos CM; Pinto DC; Cavaleiro JA; Bastos Mde L
J Enzyme Inhib Med Chem; 2002 Feb; 17(1):45-8. PubMed ID: 12365460
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors.
Mao Q; Dai X; Xu G; Su Y; Zhang B; Liu D; Wang S
Eur J Med Chem; 2019 Nov; 181():111558. PubMed ID: 31369933
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Choi SP; Kim TH; Jung CK; Lee JY; Jung SH; Kim GT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1254-8. PubMed ID: 25704891
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J
Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
